We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

which raked in billions of dollars in revenues during the pandemic. Moderna and Pfizer/BioNTech are also suing each other, for example, while GSK alliance partner CureVac has been trading blows ...

AstraZeneca has beaten analysts’ expectations in its second quarter results, outshining its UK counterpart GlaxoSmithKline, which has been hit by disruption caused by the COVID-19 pandemic.

Recent health news highlights a 10% rise in child TB infections in Europe, detected mammal bird flu cases, and economic ...